Read + Share
Amedeo Smart
Independent Medical Education
Kirchgesner J, Desai RJ, Schneeweiss MC, Beaugerie L, et al. Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease. Gut 2022;71:1781-1789.PMID: 35387877
Email
LinkedIn
Facebook
Twitter
Privacy Policy